title: Comparison of the effects of tamoxifen and of a tamoxifen analogue that does not bind the estrogen receptor on serum lipid profiles in the cockerel.
abstract: Administration of the nonsteroidal antiestrogen tamoxifen to cockerels results in dose- and time-dependent decreases in the levels of free and esterified cholesterol, phospholipids, and triglycerides in serum and in very low density and low density lipoprotein fractions. Similar changes can be elicited using a tamoxifen analogue, N,N-diethyl-2-[(4-phenylmethyl)phenoxy]ethanamine.HCl (DPPE). Like tamoxifen, this compound is capable of binding antiestrogen binding sites and exhibits a relative binding affinity of 90% compared with tamoxifen (Ki approximately 4-5 nM). Unlike tamoxifen, DPPE shows no measureable affinity for the cockerel liver nuclear estrogen receptor. Further, DPPE exhibits no estrogen agonist or antagonist activity as measured at the level of synthesis of apolipoprotein II of very low density lipoprotein by liver, synthesis of ovalbumin by oviduct, or growth of the oviduct. Although it is possible that the lipid-lowering effects of tamoxifen result from the opposition of endogenous estrogen action in the cockerel, the similarity of the effects of tamoxifen and DPPE on the lipid profiles suggests common mechanisms that do not involve the estrogen receptor.
authors.affiliation: Department of Biochemistry, Dalhousie University, Halifax, NS., Canada.
authors.forename: C B
authors.initials: CB
authors.lastname: Lazier
authors.forename: W C
authors.initials: WC
authors.lastname: Breckenridge
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D002645:Chickens; D002784:Cholesterol / Q000097:blood; D002788:Cholesterol Esters / Q000097:blood; D004958:Estradiol / Q000378:metabolism / Q000494:pharmacology; D004965:Estrogen Antagonists; D005260:Female; D008055:Lipids / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D010647:Phenyl Ethers / Q000378:metabolism / Q000494:pharmacology*; D010743:Phospholipids / Q000097:blood; D011960:Receptors, Estrogen / Q000378:metabolism*; D013629:Tamoxifen / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood
chemical_list: D002788:Cholesterol Esters; D004965:Estrogen Antagonists; D008055:Lipids; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010647:Phenyl Ethers; D010743:Phospholipids; D011960:Receptors, Estrogen; D014280:Triglycerides; D013629:Tamoxifen; D004958:Estradiol; D002784:Cholesterol; C043062:tesmilifene